TI - Irinotecan and Ifosfamide Combination is an Effective and Safe Option in Patients with Refractory Small Cell Lung Cancer: A Retrospective Cross-Sectional Study
PT - Journal Article
DP - 2020
TA - EJMO
PG - 172-176
VI - 4
IP - 2
AID - 2020.15578 [doi]
4100 - https://dx.doi.org/10.14744/ejmo.2020.15578
SO - EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY,2020 4(2): 172